Alterity Therapeutics (ATHE) Profit After Tax (2009 - 2024)
Alterity Therapeutics' (ATHE) quarterly Profit After Tax came in at -$12.8 million in Q2 2024, down 36.64% year-on-year from -$20.1 million in Q3 2023, and down 36.64% quarter-over-quarter from -$9.3 million in Q2 2023.
Alterity Therapeutics (ATHE) Profit After Tax (2009 - 2024) Analysis & Trends
Alterity Therapeutics' Profit After Tax history runs 11 years deep, the most recent figure standing at -$12.8 million for Q2 2024.
- On a quarterly basis, Profit After Tax fell 36.64% year-over-year to -$12.8 million in Q2 2024; TTM through Jun 2024 was -$35.3 million, a 12.56% decrease from a year earlier, with the FY2025 full-year figure at -$7.8 million, up 38.27% from the prior year.
- Profit After Tax declined to -$12.8 million in Q2 2024 per ATHE's latest filing, from -$9.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$9.3 million in Q2 2022 and bottomed at -$12.8 million in Q2 2024.
- The 3-year median for Profit After Tax is -$9.3 million (2023), against an average of -$10.5 million.
- Across the five-year window, Profit After Tax fell 0.1% in 2023 and tumbled 36.64% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$9.3 million in 2022, then slipped by 0.1% to -$9.3 million in 2023, then tumbled by 36.64% to -$12.8 million in 2024.
- Per Business Quant, the three latest ATHE Profit After Tax figures stand at -$12.8 million (Q2 2024), -$9.3 million (Q2 2023), and -$9.3 million (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -12.76 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Jun 30, 2022 | -9.33 Mn |
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2019 | -8.82 Mn |
| Dec 31, 2018 | -3.83 Mn |
| Jun 30, 2018 | -6.38 Mn |
| Dec 31, 2017 | -5.80 Mn |
| Jun 30, 2017 | -5.38 Mn |
| Dec 31, 2016 | -2.74 Mn |
| Jun 30, 2012 | -5.30 Mn |
| Dec 31, 2011 | -3.41 Mn |
| Jun 30, 2011 | -6.83 Mn |
| Dec 31, 2010 | -3.83 Mn |
| Jun 30, 2010 | -4.91 Mn |
| Dec 31, 2009 | -2.01 Mn |
| Jun 30, 2009 | -7.52 Mn |